Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Cash & Current Investments (2010 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) posted Cash & Current Investments of $20.95 million for Q4 2025, down 50.0% from $41.92 million a year earlier and down 29.3% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Cash & Current Investments (2010 - 2025) Analysis & Trends

Since Q2 2010, Sangamo Therapeutics has reported Cash & Current Investments for 63 quarters.

  • Annual Cash & Current Investments has declined for five consecutive years, with a five-year compound annual growth rate of -49.6% (FY2020 to FY2025).
  • In prior years, Sangamo Therapeutics' Cash & Current Investments was $41.92 million in FY2024 (-48.3%), $81 million in FY2023 (-70.8%), $277.63 million in FY2022 (-26.3%) and $376.55 million in FY2021 (-41.3%).
  • The Q4 2025 figure stands as the lowest quarterly Cash & Current Investments since Q1 2011.
  • On a year-over-year basis, Cash & Current Investments increased in 1 of the last eight quarters, with an average decline of 45.4%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2021, with growth of 63.9%; the weakest was Q2 2024, with a decline of 80.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $29.62 million (Q3 2025), $38.34 million (Q2 2025) and $25.2 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn - 20.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.95 Mn
Sep 30, 2025 29.62 Mn
Jun 30, 2025 38.34 Mn
Mar 31, 2025 25.20 Mn
Dec 31, 2024 41.92 Mn
Sep 30, 2024 39.20 Mn
Jun 30, 2024 27.79 Mn
Mar 31, 2024 54.42 Mn
Dec 31, 2023 81.00 Mn
Sep 30, 2023 132.11 Mn
Jun 30, 2023 143.10 Mn
Mar 31, 2023 205.39 Mn
Dec 31, 2022 277.63 Mn
Sep 30, 2022 313.57 Mn
Jun 30, 2022 315.72 Mn
Mar 31, 2022 317.80 Mn
Dec 31, 2021 376.55 Mn
Sep 30, 2021 423.41 Mn
Jun 30, 2021 529.65 Mn
Mar 31, 2021 587.08 Mn
API Access

Sangamo Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY